Characteristics of Nausea Reported by HIV-Infected Patients Initiating Combination Antiretroviral Regimens

Nancy Reynolds, Judith L. Neidig

Research output: Contribution to journalArticle

Abstract

Reliable data on the incidence and severity of nausea accompanying combination antiretroviral therapies is lacking. Aprospective time series design was used to assess the rate, severity, and distress of nausea in a cohort of 75 HIV-positive patients who were beginning or changing a combination of two or more antiretroviral medications. Data were collected via telephone at weekly intervals for 12 weeks. The rate of nausea across regimens was greatest at Week 1 (39%) and declined progressively over time. By Week 12, the rate of nausea was only 5%. Severity of nausea was ranked as moderate or severe by a substantial proportion of patients through Week 10; however, nausea severity and distress were also found to diminish over time. The nausea associated with combination antiretroviral therapy is quite common and may adversely affect medication adherence. Findings indicate that clinicians should consider initiating interventions for management of antiretroviral-related nausea at baseline.

Original languageEnglish (US)
Pages (from-to)71-88
Number of pages18
JournalClinical Nursing Research
Volume11
Issue number1
DOIs
StatePublished - Jan 1 2002
Externally publishedYes

Fingerprint

Nausea
HIV
Medication Adherence
Telephone
Incidence
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Characteristics of Nausea Reported by HIV-Infected Patients Initiating Combination Antiretroviral Regimens. / Reynolds, Nancy; Neidig, Judith L.

In: Clinical Nursing Research, Vol. 11, No. 1, 01.01.2002, p. 71-88.

Research output: Contribution to journalArticle

@article{31301fa37d584fd09c71d2ad8dd1d11d,
title = "Characteristics of Nausea Reported by HIV-Infected Patients Initiating Combination Antiretroviral Regimens",
abstract = "Reliable data on the incidence and severity of nausea accompanying combination antiretroviral therapies is lacking. Aprospective time series design was used to assess the rate, severity, and distress of nausea in a cohort of 75 HIV-positive patients who were beginning or changing a combination of two or more antiretroviral medications. Data were collected via telephone at weekly intervals for 12 weeks. The rate of nausea across regimens was greatest at Week 1 (39{\%}) and declined progressively over time. By Week 12, the rate of nausea was only 5{\%}. Severity of nausea was ranked as moderate or severe by a substantial proportion of patients through Week 10; however, nausea severity and distress were also found to diminish over time. The nausea associated with combination antiretroviral therapy is quite common and may adversely affect medication adherence. Findings indicate that clinicians should consider initiating interventions for management of antiretroviral-related nausea at baseline.",
author = "Nancy Reynolds and Neidig, {Judith L.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1177/105477380201100106",
language = "English (US)",
volume = "11",
pages = "71--88",
journal = "Clinical Nursing Research",
issn = "1054-7738",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Characteristics of Nausea Reported by HIV-Infected Patients Initiating Combination Antiretroviral Regimens

AU - Reynolds, Nancy

AU - Neidig, Judith L.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Reliable data on the incidence and severity of nausea accompanying combination antiretroviral therapies is lacking. Aprospective time series design was used to assess the rate, severity, and distress of nausea in a cohort of 75 HIV-positive patients who were beginning or changing a combination of two or more antiretroviral medications. Data were collected via telephone at weekly intervals for 12 weeks. The rate of nausea across regimens was greatest at Week 1 (39%) and declined progressively over time. By Week 12, the rate of nausea was only 5%. Severity of nausea was ranked as moderate or severe by a substantial proportion of patients through Week 10; however, nausea severity and distress were also found to diminish over time. The nausea associated with combination antiretroviral therapy is quite common and may adversely affect medication adherence. Findings indicate that clinicians should consider initiating interventions for management of antiretroviral-related nausea at baseline.

AB - Reliable data on the incidence and severity of nausea accompanying combination antiretroviral therapies is lacking. Aprospective time series design was used to assess the rate, severity, and distress of nausea in a cohort of 75 HIV-positive patients who were beginning or changing a combination of two or more antiretroviral medications. Data were collected via telephone at weekly intervals for 12 weeks. The rate of nausea across regimens was greatest at Week 1 (39%) and declined progressively over time. By Week 12, the rate of nausea was only 5%. Severity of nausea was ranked as moderate or severe by a substantial proportion of patients through Week 10; however, nausea severity and distress were also found to diminish over time. The nausea associated with combination antiretroviral therapy is quite common and may adversely affect medication adherence. Findings indicate that clinicians should consider initiating interventions for management of antiretroviral-related nausea at baseline.

UR - http://www.scopus.com/inward/record.url?scp=0036482970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036482970&partnerID=8YFLogxK

U2 - 10.1177/105477380201100106

DO - 10.1177/105477380201100106

M3 - Article

C2 - 11845516

AN - SCOPUS:0036482970

VL - 11

SP - 71

EP - 88

JO - Clinical Nursing Research

JF - Clinical Nursing Research

SN - 1054-7738

IS - 1

ER -